SGC-UBD-253

N/A

Report date: 2023/08/01 17:41:20
NME

Base Information

Drug NameSGC-UBD-253
Drug Alias NameSGC-UBD253SGC-UBD-253
ClassificationSmall molecules
Mechanisms of ActionHistone deacetylase 6 antagonists
TargetsHistone deacetylase 6
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Toronto, Toronto
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Toronto, Toronto
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A